Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience
04 Noviembre 2024 - 8:00AM
Business Wire
Collaboration to leverage Praia Health’s
technology and Labcorp’s comprehensive testing capabilities to
streamline and personalize patient experience
Praia Health, the consumer experience orchestration platform for
health systems, is pleased to announce it has secured a strategic
investment from the Labcorp Venture Fund and will collaborate with
Labcorp, a global leader of innovative and comprehensive laboratory
services, to streamline and personalize the patient experience for
lab orders and testing within select health systems.
“Our collaboration with Labcorp represents a significant step
forward in delivering personalized and seamless healthcare
experiences,” said Justin Dearborn, CEO at Praia Health. “We are
thrilled to work together to bring these benefits to patients
nationwide.”
Praia Health’s platform identifies patients with lab orders and
provides tailored notifications and cards within a health system’s
mobile application or logged-in web experience. Patients can easily
schedule lab tests ordered by their physicians and find the closest
appropriate Labcorp facility, ensuring their specific testing and
lab requirements are met, including service availability, operating
hours and staffing.
“This collaboration aligns with our commitment to provide
physicians and patients with expanded access to high-quality,
comprehensive and convenient lab services,” said Bryan Vaughn,
Labcorp’s SVP, Health and Hospital Systems and Mid-America
Division. “We look forward to what the future holds as we leverage
Praia Health’s innovative technology to enhance the patient
experience.”
The collaboration will initially launch at Providence, one of
the nation’s largest and most innovative health systems, at their
Puget Sound location.
“By simplifying the process for lab orders and testing, we are
making healthcare more accessible and convenient for our patients.
This initiative represents a significant advancement in enhancing
the overall patient experience,” said Andy Chu, Providence’s SVP of
Product and Technology Incubation.
Labcorp and Praia Health anticipate expanding access to other
hospitals and health systems across the country. To learn more
about these capabilities, contact Praia Health at Contact
(praiahealth.com) or Labcorp at
https://insights.labcorp.com/HealthSystemsContactUs.
About Praia Health
Incubated at Providence, one of the nation’s largest and most
innovative health systems, Praia Health™ is an experience
orchestration platform for health systems that is revolutionizing
the delivery of individualized health solutions at scale. In April
2024, Praia announced the closing of a $20 million oversubscribed
Series A financing round led by Frist Cressey Ventures and backed
by SignalFire, Epsilon Health Investors, Providence Ventures and
Labcorp. For more information about Praia Health, visit
praiahealth.com and follow them on LinkedIn.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and
comprehensive laboratory services that helps doctors, hospitals,
pharmaceutical companies, researchers and patients make clear and
confident decisions. We provide insights and advance science to
improve health and improve lives through our unparalleled
diagnostics and drug development laboratory capabilities. The
company's more than 67,000 employees serve clients in approximately
100 countries, provided support for 84% of the new drugs and
therapeutic products approved in 2023 by the FDA and performed more
than 600 million tests for patients around the world. Learn more
about us at www.labcorp.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241104176840/en/
Media Contact: Jared Johnson, Chief Marketing Officer, Praia
Health jared@praiahealth.com 972-561-0025
Labcorp (NYSE:LH)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Labcorp (NYSE:LH)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024